Current Perspective on Pricing and Reimbursement Models
Leading stakeholders in the industry react to how evolving US policies, payer demands, and vertical integration are reshaping market access strategy, stressing the importance of early planning and the urgency of ensuring that innovative therapies are available and affordable for patients.
This Peer Exchange® starts off with an introduction of the panel: Edward Ahn, CEO of MEDIPOST, Inc.; Rob Philo, Founder and CEO of Core Market Access Advisors; and Shana Gunderson Hua, PharmD, Vice President of Value & Access at Petauri Advisors. Moderated by Ed Schoonveld, Value and Access Advisor at Schoonveld Advisory, LLC and columnist for Pharmaceutical Commerce, the discussion begins with the panelists reflecting on recent policy changes, including the anticipated Medicare Part D updates, and clinical trial design that satisfies FDA requirements and payer expectations.
Key discussion topics include:
- Recent policy changes in the pharmaceutical landscape and what this could mean for payers.
- The current design of trial, pricing, and reimbursement models.
